Sylvia Koivunen

Title: Sylvia Koivunen: Innovator in Biomolecule Delivery Technology

Introduction

Sylvia Koivunen is a prominent inventor based in Helsingborg, Sweden. She has made significant contributions to the field of biomolecule delivery, particularly through her innovative work on nanoparticles. Her research focuses on enhancing the delivery of biomolecules into or out of membrane-enclosed cells, which has important implications for medical and biotechnological applications.

Latest Patents

Koivunen holds a patent for a nanoparticle designed for the delivery of biomolecules. The patent describes a nano-sized particle that facilitates in vitro or ex vivo biomolecule delivery to cell cultures through heat-induced endosomal release. This innovative particle features a superparamagnetic core coated with a heat-sensitive layer, which includes membrane-disruptive components and binding sites for biomolecules and markers. The method outlined in her patent involves applying an alternating field to a cell culture containing the described particles, enabling the release of biomolecules and the disruption of endosomal membranes.

Career Highlights

Sylvia Koivunen is currently employed at Genovis AB, a company known for its advancements in biotechnology. Her work at Genovis has allowed her to collaborate with other talented professionals in the field, contributing to the development of cutting-edge technologies.

Collaborations

Koivunen has worked alongside colleagues such as Sarah Fredriksson and Fredrik Olsson. These collaborations have fostered a dynamic research environment, enhancing the potential for innovative breakthroughs in biomolecule delivery systems.

Conclusion

Sylvia Koivunen's contributions to the field of biomolecule delivery through her patented nanoparticle technology exemplify her role as a leading inventor. Her work at Genovis AB and collaborations with fellow researchers continue to push the boundaries of biotechnology.